Save time and get answers to complex questions with AI chat
Complera ingredients?Xenazine current manufacturer 2025?Bortezomib market france?Are there specific stretches to avoid while on lipitor?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for Mounjaro
Mounjaro is a brand name for a medication whose generic name is tirzepatide. It is an injectable prescription drug used for type 2 diabetes and has also been studied/used for weight-related indications depending on the regulatory approvals in the user’s country.
As a brand, “Mounjaro” refers specifically to tirzepatide. If a generic or biosimilar-style alternative is available in your region, it would typically be listed under the generic name tirzepatide rather than “Mounjaro,” but availability depends on local approvals and patent/law status.
Mounjaro is made by Eli Lilly and Company.
For updates on patents and market exclusivity for Mounjaro/tirzepatide, DrugPatentWatch.com tracks relevant filings and timelines: https://www.drugpatentwatch.com/ Sources: 1. DrugPatentWatch.com
Other Questions About Mounjaro :